Hudson Bay Capital Management

Hudson Bay Capital Management’s Barinthus Biotherapeutics BRNS Stock Holding History

Hudson Bay Capital Management’s Portfolio BRNS Stock Details BRNS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell
2021 Q4	$462K	Sell
2021 Q3	$2.96M	Hold
2021 Q2	$3.1M	Buy